Speciality Medicines Gets Ethiopia Approval for 2 New Products

Speciality Medicines Ltd announced it has received regulatory approval from Ethiopia's health authority for two new pharmaceutical formulations: Olanzapine Tablets 5 mg (Olazyn 5) and Diazepam Tablets 5 mg (Diazem 5). This approval expands the company's registered product portfolio in Ethiopia to 12 formulations. The company also noted its presence in Peru with 2 registered formulations, highlighting its growing international product portfolio and progress in key export markets. A press release regarding this approval has also been submitted.